FUJIFILM Signs $3B Deal With Regeneron For Biologics Work In Holly Springs

FUJIFILM Diosynth Biotechnologies, a leading global contract development and manufacturing organization (CDMO) with a significant presence in North Carolina, has entered into a landmark agreement with Regeneron Pharmaceuticals valued at over $3 billion. This long-term partnership underscores the growing demand for advanced biologics manufacturing capabilities in the United States. This strategic collaboration not only strengthens FUJIFILM Diosynth Biotechnologies’ position as a premier CDMO in the biopharmaceutical sector but also highlights the importance of resilient, U.S.-based supply chains for life-saving medicines.

Access the full article to learn more.